Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration212Abbreviations: HSV, herpes simplex virus; CGE, capillary gel electrophoresis; and HPLC/ES-MS, high performance liquid chromatography/electrospray-mass spectrometry.1Johnston J, ISIS Pharmaceuticals, personal communication. Cited with permission.-Reference-Cited by-同舟云学术

Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration212Abbreviations: HSV, herpes simplex virus; CGE, capillary gel electrophoresis; and HPLC/ES-MS, high performance liquid chromatography/electrospray-mass spectrometry.1Johnston J, ISIS Pharmaceuticals, personal communication. Cited with permission.

Published:2001-08 Issue:3 Volume:62 Page:297-306
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Graham Mark J.,Crooke Stanley T.,Lemonidis Kristina M.,Gaus Hans J.,Templin Michael V.,Crooke Rosanne M.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference36 articles.

1. Basic principles of antisense therapeutics;Crooke,1998

2. Progress in antisense therapeutics;Crooke,1999

3. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats;Cossum;J Pharmacol Exp Ther,1994

4. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression;Geary;Drug Metab Dispos,1997

5. Antisense oligonucleotide inhibitors for the treatment of cancer;Geary;Anticancer Drug Des,1997

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond;Current Drug Metabolism;2023-07

2. Altered Biodistribution and Hepatic Safety Profile of a Gapmer Antisense Oligonucleotide Bearing Guanidine-Bridged Nucleic Acids;Nucleic Acid Therapeutics;2022-06-01

3. Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis;Biomedicines;2021-08-09

4. Antisense technology: an overview and prospectus;Nature Reviews Drug Discovery;2021-03-24

5. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non‐alcoholic steatohepatitis;Journal of Gastroenterology and Hepatology;2020-05-13